Drawing for CX

USPTO serial 79235746

CX

Reviewed by CopyMark Law Group

Reg. 5772092Status 739Registered
Filing date
Status date
Registration date
Jun 11, 2019
Examiner
FIRST, VIVIAN M
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany D. Gehrke

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP233 S Wacker Drive6300 Willis TowerChicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic biomarker reagents for medical purposes, diagnostic preparations for medical purposes, none of the foregoing for use in cell culturesACTIVE—
010Medical test kits comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, devices, apparatuses, and analysis instruments for carrying out assays for medical purposes including prognosis, diagnosis and monitoring, none of the foregoing for use in cell cultures; medical test kits comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, devices, apparatuses and instruments for collection of samples for the purposes of medical prognosis, diagnosis and monitoring, none of the foregoing for use in cell cultures; [ blood ] and urine [ sampling and analysis ] systems comprising medical sample tubes, medical specimen cups, absorbent pads, medical test request forms and instructions, none of the foregoing for use in cell cultures; all of the aforementioned goods for the purpose of prognosis, diagnosis, detection or monitoring of the risk or presence of cancer, especially bladder cancer [, gastric cancer, colorectal cancer, endometrial cancer, and melanoma ]ACTIVE—
044Health and medical assessment, evaluation and diagnostic services, including the prognostic and diagnostic testing of biological samples especially [ blood and ] urine, including for the prognostic and diagnostic testing, monitoring and reporting of cancer, including bladder cancer, [ gastric cancer, colorectal cancer, endometrial cancer, and melanoma, ] none of the foregoing relate to cell culturesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Sep 11, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 5, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Jun 11, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 31, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 31, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 31, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 31, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 21, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 21, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 20, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 20, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 20, 2022EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Oct 20, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 20, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 20, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 12, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 21, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 21, 2019FIMPFINAL DISPOSITION PROCESSED—
Sep 11, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 11, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 23, 2019GPNXNOTIFICATION PROCESSED BY IB—
Mar 6, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 6, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 6, 2019NPUBNOTICE OF PUBLICATION—
Feb 15, 2019ALIEASSIGNED TO LIE—
Feb 5, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 31, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 31, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 18, 2018RFNTREFUSAL PROCESSED BY IB—
Aug 13, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 13, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 2, 2018RFRRREFUSAL PROCESSED BY MPU—
Jul 18, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 17, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 10, 2018RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jul 10, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 10, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2018DOCKASSIGNED TO EXAMINER—
Jul 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 5, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance